Seaport Therapeutics, Inc. (SPTX)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 1 signal for Seaport Therapeutics, Inc.. Most notable: 2026-06-22: HOMBACH ROBERT J. (director) bought $236k of stock. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Insider purchaseHOMBACH ROBERT J. (director) bought $236k of stock
- Insider purchaseARCH Venture Partners XII, LLC; ARCH Venture Partners XII, L.P.; ARCH Venture Fund XII, L.P.; CRANDELL KEITH; NELSEN ROBERT; Burow Kristina; GILLIS STEVEN (ten_percent_owner) bought $19.8M of stock
- Insider purchaseARCH Venture Partners XII, L.P. (ten_percent_owner) bought $19.8M of stock
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | HOMBACH ROBERT J. | director | P | 13,000 | 18.14 | $235,820 |
| 2026-06-22 | HOMBACH ROBERT J. | director | P | 13,000 | 18.14 | $235,768 |
| 2026-05-04 | PureTech Health plc | ten percent owner | C | 2,681,265 | — | — |
| 2026-05-04 | PureTech Health plc | ten percent owner | C | 965,255 | — | — |
| 2026-05-04 | PureTech Health plc | ten percent owner | C | 12,736,014 | — | — |
| 2026-05-04 | HEALY JAMES | director | C | 804,379 | — | — |
| 2026-05-04 | HEALY JAMES | director | C | 1,927,159 | — | — |
| 2026-05-04 | White Lauren | officer | C | 6,702 | — | — |
| 2026-05-04 | Gladstein Lana | officer | C | 33,515 | — | — |
| 2026-05-04 | Chen Michael Cunyuan | officer | C | 3,351 | — | — |
| 2026-05-04 | Torres Denice | director | C | 13,406 | — | — |
| 2026-05-04 | PAUL STEVEN M | director | C | 67,031 | — | — |
| 2026-05-04 | ARCH Venture Partners XII, L.P. | ten percent owner | P | 1,100,000 | 18 | $19,800,000 |
| 2026-05-04 | ARCH Venture Partners XII, L.P. | ten percent owner | C | 2,681,265 | — | — |
| 2026-05-04 | ARCH Venture Partners XII, L.P. | ten percent owner | C | 2,513,686 | — | — |
| 2026-05-04 | Loebel Antony | officer | C | 20,109 | — | — |
| 2026-05-04 | PureTech Health plc; PureTech LYT, Inc. | ten percent owner | C | 12,736,014 | — | — |
| 2026-05-04 | PureTech Health plc; PureTech LYT, Inc. | ten percent owner | C | 2,681,265 | — | — |
| 2026-05-04 | PureTech Health plc; PureTech LYT, Inc. | ten percent owner | C | 965,255 | — | — |
| 2026-05-04 | HEALY JAMES | director | C | 1,927,159 | — | — |
| 2026-05-04 | HEALY JAMES | director | C | 804,379 | — | — |
| 2026-05-04 | White Lauren | officer | C | 6,702 | — | — |
| 2026-05-04 | Gladstein Lana | officer | C | 33,515 | — | — |
| 2026-05-04 | Chen Michael Cunyuan | officer | C | 3,351 | — | — |
| 2026-05-04 | Torres Denice | director | C | 13,406 | — | — |
| 2026-05-04 | PAUL STEVEN M | director | C | 67,031 | — | — |
| 2026-05-04 | ARCH Venture Partners XII, LLC; ARCH Venture Partners XII, L.P.; ARCH Venture Fund XII, L.P.; CRANDELL KEITH; NELSEN ROBERT; Burow Kristina; GILLIS STEVEN | ten percent owner | C | 2,513,686 | — | — |
| 2026-05-04 | ARCH Venture Partners XII, LLC; ARCH Venture Partners XII, L.P.; ARCH Venture Fund XII, L.P.; CRANDELL KEITH; NELSEN ROBERT; Burow Kristina; GILLIS STEVEN | ten percent owner | C | 2,681,265 | — | — |
| 2026-05-04 | ARCH Venture Partners XII, LLC; ARCH Venture Partners XII, L.P.; ARCH Venture Fund XII, L.P.; CRANDELL KEITH; NELSEN ROBERT; Burow Kristina; GILLIS STEVEN | ten percent owner | P | 1,100,000 | 18 | $19,800,000 |
| 2026-05-04 | Loebel Antony | officer | C | 20,109 | — | — |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-08-14 SCHEDULE 13G
- 2026-08-05 SCHEDULE 13G
- 2026-08-05 SCHEDULE 13G
- 2026-08-03 10-Q
- 2026-08-03 8-K
- 2026-06-24 4
- 2026-06-08 10-Q
- 2026-06-08 8-K
- 2026-05-11 SCHEDULE 13D
- 2026-05-11 SCHEDULE 13G
- 2026-05-06 3
- 2026-05-06 3
- 2026-05-06 4
- 2026-05-06 SCHEDULE 13D
- 2026-05-04 4
- 2026-05-04 4
- 2026-05-04 4
- 2026-05-04 4
- 2026-05-04 4
- 2026-05-04 4